
| Ophthalmic Indications |
|
Products & Technologies |
| News & Media |
| Careers |
| Contact Us |
| A. Clarke Atwell | |
|
Founder, Chief Operating Officer
Mr. Atwell is the Chief
Operating Officer at Lux Biosciences Inc. Previously, Mr. Atwell served
as the Vice President of Sales and Marketing at Enzon Pharmaceuticals
Inc. In this role he was responsible for all aspects of the marketing of
a diverse specialty product portfolio (Oncology, Transplantation and
Infectious Disease) with a 70 person sales team. Mr. Atwell was
responsible for building Enzon’s entire commercial infrastructure in
less than two months. Mr. Atwell served as
Director of Transplantation for Roche within the U.S., where he was
responsible for the launch and growth of CellCept®
into the leading immunosuppressive within the U.S. Market. This growth
was based on the ability to build a sustainable franchise based on
market leadership, a robust clinical program, and strong community based
programs. Mr. Atwell has 16 years
of Marketing, Sales and Business Development experience, in both small
biotechnology companies as well as global pharmaceutical companies.
© 2008 Lux Biosciences, Inc. All rights reserved. Web Terms
|